New frontiers and clinical applications for botulinum neuromodulators

Dermatol Surg. 2015 Jan:41 Suppl 1:S17-8. doi: 10.1097/DSS.0000000000000278.

Authors

Jared Jagdeo¹, Alastair Carruthers, Kevin C Smith

Affiliation

¹ Department of Dermatology, UC Davis Medical Center, Sacramento, California, Dermatology Service, Sacramento VA Medical Center, Mather, California, Department of Dermatology, SUNY Downstate Medical Center, Brooklyn, New York Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada Private Practice, Niagara Falls, Ontario, Canada.

PMID: 25548840
DOI: 10.1097/DSS.0000000000000278

No abstract available

MeSH terms

Acetylcholine Release Inhibitors / therapeutic use
Botulinum Toxins, Type A / therapeutic use*
Humans
Migraine Disorders / drug therapy
Neurotoxins / therapeutic use
Pain / drug therapy
Skin Diseases / drug therapy

Substances

Acetylcholine Release Inhibitors
Neurotoxins
Botulinum Toxins, Type A